Accelerate biotechnology

Accelerated viral vector production

Batavia Biosciences deploys state-of-the-art R&D and clean room production facilities dedicated to the manufacture of viral vectors. The staff at Batavia has a 100% track record in delivering viral vector-based products in INDs. At Batavia we accelerate biopharmaceutical product development with guaranteed short delivery timelines.

Viral vectors

Our in-depth experience in the manufacture of viral vectors spans across the board, from the manipulation of the vector backbone, generation of recombinant vector from RNA of DNA, generation of (pre-)master virus seeds, process development and scale-up, analytical development, up to and including clinical manufacturing. Integration of all these steps into one seamless process allows rapid delivery your viral vector. Our experience with vectors covers lentiviruses, Adeno-associated viruses (AAV), Measles, Adenoviruses, Vesicular stomatitis virus (VSV) and cytomegalovirus (CMV).

Efficient viral vector production using SIDUS® technology

Batavia Biosciences’ SIDUS® technology platform ensures well-defined, rapid and cost-efficient production of diverse vector-based products. The platform is anchored in work instructions, pre-selected, GMP compliant raw materials, protocols and manufacturing equipment such that we are able to rapidly scale-up vector production processes from miniature bioreactors (2-20 mL) to 200 liter scale disposable reactors (please download our SIDUS® technology factsheet to read more). Most importantly, the technology platform encompasses all the release assays and therefore quickly allows us to monitor the efficiency of the process (production / purification) and release of vector-based products. Batavia Biosciences’ experienced in house Qualified Person, Quality Assurance system and Quality Control department facilitate the release of your clinical product.

As a company dedicated to bringing biopharmaceuticals to the market at higher speed, with reduced costs, and with a higher success rate, Batavia Biosciences has ample experience in developing various vector-based products. The team of experienced researchers use the newest technologies and are well equipped to take on any challenge associated with viral vector development.

Contact us for vector development and production solutions

Virus & Cell banking

Preclinical material manufacturing

Clinical Manufacturing